Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel

被引:20
作者
Chachin, M
Katayama, Y
Yamada, M
Horio, Y
Ohmura, T
Kitagawa, H
Uchida, S
Kurachi, Y
机构
[1] Osaka Univ, Fac Med, Dept Pharmacol 2, Osaka 5650871, Japan
[2] Nippon Boehringer Ingelheim, Kawanishi Pharma Res Inst, Dept Pharmacol, Kawanishi 6660193, Japan
[3] Natl Cardiovasc Res Inst, Dept Cardiac Physiol, Osaka 5658565, Japan
关键词
histamine H-1 receptor antagonist; epinastine; terfenadine; astemizole; HERG; K+ channel;
D O I
10.1016/S0014-2999(99)00375-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Terfenadine and astemizole rarely cause cardiac arrhythmias by suppressing the cardiac rapid delayed rectifier K+ channel encoded by the human ether-a-go-go-related gene (HERG). Epinastine, however, has not been reported to have the adverse effect. We have therefore compared the effects of epinastine, terfenadine and astemizole on HERG channels expressed in Xenopus oocytes. Terfenadine and astemizole suppressed the HERG current with IC50 of 431 nM and 69 nM, respectively. In contrast, 100 mu M epinastine inhibited the HERG current by only 11 +/- 2.1%. These results may provide an explanation for the difference in the cardiotoxity between different nonsedating histamine H-1 receptor antagonists. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:457 / 460
页数:4
相关论文
共 11 条
[1]   Effects of cetirizine on the delayed K+ currents in cardiac cells:: comparison with terfenadine [J].
Carmeliet, E .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (04) :663-668
[2]  
FUGNER A, 1988, ARZNEIMITTEL-FORSCH, V38-2, P1446
[3]   RATE-DEPENDENT PROLONGATION OF CARDIAC ACTION-POTENTIALS BY A METHANESULFONANILIDE CLASS-III ANTIARRHYTHMIC AGENT - SPECIFIC BLOCK OF RAPIDLY ACTIVATING DELAYED RECTIFIER K+-CURRENT BY DOFETILIDE [J].
JURKIEWICZ, NK ;
SANGUINETTI, MC .
CIRCULATION RESEARCH, 1993, 72 (01) :75-83
[4]  
KOMUNE T, 1999, IN PRESS RES COMMUN
[5]   TORSADES-DE-POINTES OCCURRING IN ASSOCIATION WITH TERFENADINE USE [J].
MONAHAN, BP ;
FERGUSON, CL ;
KILLEAVY, ES ;
LLOYD, BK ;
TROY, J ;
CANTILENA, LR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (21) :2788-2790
[6]   TORSADE-DE-POINTES INDUCED BY ASTEMIZOLE IN A PATIENT WITH PROLONGATION OF THE QT INTERVAL [J].
SAKEMI, H ;
VANNATTA, B .
AMERICAN HEART JOURNAL, 1993, 125 (05) :1436-1438
[7]   CARDIAC ELECTROPHYSIOLOGICAL ACTIONS OF THE HISTAMINE H-1-RECEPTOR ANTAGONISTS ASTEMIZOLE AND TERFENADINE COMPARED WITH CHLORPHENIRAMINE AND PYRILAMINE [J].
SALATA, JJ ;
JURKIEWICZ, NK ;
WALLACE, AA ;
STUPIENSKI, RF ;
GUINOSSO, PJ ;
LYNCH, JJ .
CIRCULATION RESEARCH, 1995, 76 (01) :110-119
[8]   A MECHANISTIC LINK BETWEEN AN INHERITED AND AN ACQUIRED CARDIAC-ARRHYTHMIA - HERG ENCODES THE I-KR POTASSIUM CHANNEL [J].
SANGUINETTI, MC ;
JIANG, CG ;
CURRAN, ME ;
KEATING, MT .
CELL, 1995, 81 (02) :299-307
[9]   Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines [J].
Taglialatela, M ;
Pannaccione, A ;
Castaldo, P ;
Giorgio, G ;
Zhou, ZF ;
January, CT ;
Genovese, A ;
Marone, G ;
Annunziato, L .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :113-121
[10]   IS THERE A DIFFERENCE IN THE AFFINITY OF HISTAMINE H-1-RECEPTOR ANTAGONISTS FOR CNS AND PERIPHERAL RECEPTORS - AN INVITRO STUDY [J].
TERLAAK, AM ;
DONNEOPDENKELDER, GM ;
BAST, A ;
TIMMERMAN, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 232 (2-3) :199-205